Quetiapine Fumarate
Quetiapine Fumarate is a pharmaceutical drug with 46 clinical trials. Currently 1 active trials ongoing. Historical success rate of 92.9%.
Success Metrics
Based on 39 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
3
Mid Stage
32
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.7%
39 of 43 finished
9.3%
4 ended early
1
trials recruiting
46
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)
Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury
SGA-induced Metabolic Syndrome in Bipolar Youth
Quetiapine and the Dopaminergic Epigenetic Control
Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
Clinical Trials (46)
Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)
Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury
SGA-induced Metabolic Syndrome in Bipolar Youth
Quetiapine and the Dopaminergic Epigenetic Control
Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed Conditions
Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions
Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions
A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study
A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia
Quetiapine for the Reduction of Cocaine Use
Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients
A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder
Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder
Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania
Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder
Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression
Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder
Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition
Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 46